These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2286433)

  • 1. Efficacy of three doses of oral polio immunization beginning within the first four days of life.
    Bhatawdekar AM; Kumta NB; Dave KH; Bharucha BA
    Indian Pediatr; 1990 Sep; 27(9):911-4. PubMed ID: 2286433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early immunization of neonates with trivalent oral poliovirus vaccine.
    Weckx LY; Schmidt BJ; Herrmann AA; Miyasaki CH; Novo NF
    Bull World Health Organ; 1992; 70(1):85-91. PubMed ID: 1314711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons from Cuba: mass campaign administration of trivalent oral poliovirus vaccine and seroprevalence of poliovirus neutralizing antibodies.
    Mas Lago P; Ramon Bravo J; Andrus JK; Comellas MM; Galindo MA; de Quadros CA; Bell E
    Bull World Health Organ; 1994; 72(2):221-5. PubMed ID: 8205641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thermostability and immunogenicity of trivalent oral poliovirus vaccine produced by different countries].
    Kong J
    Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Jun; 14(3):151-4. PubMed ID: 8221837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and safety evaluation of bivalent types 1 and 3 oral poliovirus vaccine by comparing different poliomyelitis vaccination schedules in China: A randomized controlled non-inferiority clinical trial.
    Qiu J; Yang Y; Huang L; Wang L; Jiang Z; Gong J; Wang W; Wang H; Guo S; Li C; Wei S; Mo Z; Xia J
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-10. PubMed ID: 28362135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody response to three doses of standard and double dose of trivalent oral polio vaccine.
    Agarwal A; Sharma D; Kumari S; Khare S
    Indian Pediatr; 1991 Oct; 28(10):1141-5. PubMed ID: 1665840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, controlled trial of trivalent oral poliovirus vaccine (Sabin) starting at birth in Ghana.
    Osei-Kwasi M; Afari EA; Mimura K; Obeng-Ansah I; Ampofo WK; Nkrumah FK
    Bull World Health Organ; 1995; 73(1):41-6. PubMed ID: 7704924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization of neonates with trivalent oral poliomyelitis vaccine (Sabin).
    Dong DX; Hu XM; Liu WJ; Li JS; Jin YC; Tan SG; Chen TQ; Fu JZ; Niu BY; Yu HM
    Bull World Health Organ; 1986; 64(6):853-60. PubMed ID: 3493854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A study on immunization of polio vaccine. I. Observation on an improved immunization schedule].
    Su W
    Zhonghua Liu Xing Bing Xue Za Zhi; 1991 Oct; 12(5):281-3. PubMed ID: 1664295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC; Modlin JF
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy of trivalent oral poliomyelitis vaccine: a case-control study.
    Deivanayagam N; Nedunchelian K; Ahamed SS; Rathnam SR
    Bull World Health Organ; 1993; 71(3-4):307-9. PubMed ID: 8324848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The immunogenicity of vaccines against diphtheria, tetanus, pertussis and polio administered orally on the vaccinal calendar at the age of 2, 4 and 6 months and their coadministration with a hepatitis B vaccine at 0, 2 and 6 months].
    Arístegui Fernández J; Muñiz Saitua J; Pérez Legorburu A; Imaz Pérez M; Arrate Zugazabeitia JP; Suárez Fernández MD; Goiri Zabala MD
    An Esp Pediatr; 1996 Jan; 44(1):25-8. PubMed ID: 8849056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of polio immunization, with recent legal implications.
    Van Reken DE
    J Fam Pract; 1976 Dec; 3(6):603-5. PubMed ID: 1003132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of a combined schedule of trivalent oral and inactivated polio vaccines in South African infants.
    Moonsamy S; Suchard MS; Madhi SA
    Expert Rev Vaccines; 2019 Jul; 18(7):751-754. PubMed ID: 31194605
    [No Abstract]   [Full Text] [Related]  

  • 15. Monovalent type 1 oral poliovirus vaccine among infants in India: report of two randomized double-blind controlled clinical trials.
    John TJ; Jain H; Ravishankar K; Amaresh A; Verma H; Deshpande J; Pallansch MA; Singh AP; Sreevatsava M; Burton A; Malankar P; Chatterjee A; Sutter RW
    Vaccine; 2011 Aug; 29(34):5793-801. PubMed ID: 21641951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Childhood mortality after oral polio immunisation campaign in Guinea-Bissau.
    Aaby P; Hedegaard K; Sodemann M; Nhante E; Veirum JE; Jakobsen M; Lisse I; Jensen H; Sandström A
    Vaccine; 2005 Feb; 23(14):1746-51. PubMed ID: 15705481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoprophylaxis in poliomyelitis.
    John TJ
    J Commun Dis; 1984 Mar; 16(1):38-42. PubMed ID: 12055784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A controlled trial with inactivated poliovaccine.
    Swartz TA; Ben-Porath E; Ben-Yshai Z; Weissmann Z; Kanaaneh A; Leitner L; Goldblum N
    Dev Biol Stand; 1981; 47():199-206. PubMed ID: 7014297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age for assessment of trivalent oral polio vaccination coverage: is there a need for revision in India.
    Deivanayagam N; Mala N; Nedunchelian K; Ashok TP; Ahmed SS
    Indian Pediatr; 1991 Jun; 28(6):665-8. PubMed ID: 1748517
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.